Team:UCL London

From 2010.igem.org

(Difference between revisions)
Line 128: Line 128:
<script type="text/javascript" >
<script type="text/javascript" >
jQuery(document).ready(function(){
jQuery(document).ready(function(){
 +
var hacScroller = setInterval(function(){
 +
jQuery('.selected').jQuery(lastBlock).animate({width:'50px'}, {duration: 200, queue: false}).removeClass('selected').next().jQuery(this).animate({width: maxWidth + 'px'}, {duration: 200, queue: false}).addClass('selected');
 +
}, 5000);
 +
 +
lastBlock = jQuery("#hac .selected");
lastBlock = jQuery("#hac .selected");
maxWidth = 350;
maxWidth = 350;

Revision as of 20:58, 27 October 2010

UCL IGEM 2010

RETURN TO IGEM 2010

  • Project Hypoxon aims to create cells capable of self-induction into the production phase, without the introduction of any chemical into the closed system.


    Project HYPOXON

  • We are an interdisciplinary group of students and advisers. Click to find out more!
    iGEM Team

  • The construction of biological circuits was theoretically designed for more accurate prediction of its performance. Click to check out our project moedlling. Modeling

  • Want to read the detailed reports of all the collaborations that we've made over the summer??
    Collaborations

  • We've had a great time using dozens of biobricks, check them out! BioBricks

  • We are aiming for GOLD no doubt, that means we need to characterise our biobricks, so check out all of the characterisations that we've done!
    Characterisation

  • Want to know exactly what we've been doing on a daily basis and to find out how Project Hypoxon has progressed, visit our Notebook.
    Notebook

  • We would like to thank all our sponsors for their contribution and support throughout this summer project. To find out more about who did what, follow this link.
    Sponsors

Project Hypoxon

UCL’s Biochemical engineering department has been at the forefront of biopharmaceutical manufacture for years. Extraordinary advances in the life sciences have great potential to improve our quality of life through better medicines and a cleaner environment. We aim to revolutionise the way the Biopharmaceutical Industry by introducing this auto-inducible process.

Retrieved from "http://2010.igem.org/Team:UCL_London"